Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2
Clinical trial NCT00040586 · COMPLETED
Trial details
- NCT number
- NCT00040586
- Sponsor
- BZL Biologics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.